The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECT.
Teerlink JR, Iragui VJ, Mohr JP, Carson PE, Hauptman PJ, Lovett DH, Miller AB, Piña IL, Thomson S, Varosy PD, Zile MR, Cleland JG, Givertz MM, Metra M, Ponikowski P, Voors AA, Davison BA, Cotter G, Wolko D, Delucca P, Salerno CM, Mansoor GA, Dittrich H, O'Connor CM, Massie BM.
Teerlink JR, et al. Among authors: davison ba.
Drug Saf. 2012 Mar 1;35(3):233-44. doi: 10.2165/11594680-000000000-00000.
Drug Saf. 2012.
PMID: 22339573
Clinical Trial.